Xuan Chen
Huairou, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.
Journal: Communications medicine
Published: July 14, 2025
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.
Journal: Med (New York, N.Y.)
Published: April 01, 2025
Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.
Journal: Cell reports. Medicine
Published: March 07, 2025
Targeting tumor-associated macrophage-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.
Journal: Neuro-oncology
Published: January 18, 2025
Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.
Journal: Neuro-oncology
Published: January 18, 2025
Spatiotemporal transcriptome atlas of human embryos after gastrulation.
Journal: Nature
Published: August 19, 2024
Multi-omics approach reveals the impact of prognosis model-related genes on the tumor microenvironment in medulloblastoma.
Journal: Frontiers in oncology
Published: August 08, 2024
High cellular plasticity state of medulloblastoma local recurrence and distant dissemination.
Journal: Cell reports. Medicine
Published: May 27, 2024
Single-cell transcriptomic sequencing identifies subcutaneous patient-derived xenograft recapitulated medulloblastoma.
Journal: Animal models and experimental medicine
Published: November 08, 2023
Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation.
Journal: Molecular genetics & genomic medicine
Published: August 28, 2023
Last Updated: 09/26/2026